OrthoPediatrics Corp. (NASDAQ: KIDS) is one of 19 publicly-traded companies in the “Medical Devices & Implants” industry, but how does it contrast to its competitors? We will compare OrthoPediatrics Corp. to related businesses based on the strength of its profitability, analyst recommendations, valuation, risk, earnings, institutional ownership and dividends.

Valuation and Earnings

This table compares OrthoPediatrics Corp. and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
OrthoPediatrics Corp. N/A N/A 19.60
OrthoPediatrics Corp. Competitors $1.67 billion $207.58 million 70.17

OrthoPediatrics Corp.’s competitors have higher revenue and earnings than OrthoPediatrics Corp.. OrthoPediatrics Corp. is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for OrthoPediatrics Corp. and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics Corp. 0 0 4 0 3.00
OrthoPediatrics Corp. Competitors 109 727 1023 10 2.50

OrthoPediatrics Corp. currently has a consensus target price of $23.67, indicating a potential upside of 25.75%. As a group, “Medical Devices & Implants” companies have a potential upside of 34.85%. Given OrthoPediatrics Corp.’s competitors higher probable upside, analysts plainly believe OrthoPediatrics Corp. has less favorable growth aspects than its competitors.

Institutional & Insider Ownership

42.4% of shares of all “Medical Devices & Implants” companies are held by institutional investors. 9.6% of shares of all “Medical Devices & Implants” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares OrthoPediatrics Corp. and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OrthoPediatrics Corp. N/A N/A N/A
OrthoPediatrics Corp. Competitors -101.83% -92.87% -30.39%

OrthoPediatrics Corp. Company Profile

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems. Its products include RESPONSE Spinal Deformity System, PediNail Intramedullary Nail System, PediLoc Plating Systems, ACL Reconstruction System, Locking Cannulated Blade (LCB) plate system, Locking Proximal Femur (LPF) plate system, PediFlex Flexible Nailing System, PediFrag, PediLoc Extension Osteotomy Plate (PLEO), PediLoc Femur Locking Plate System, PediLoc Tibia Locking Plate System, PediPlates system and Spica Table. It markets over 20 surgical systems that serve approximately three categories within pediatric orthopedic market, including trauma and deformity, complex spine and anterior cruciate ligament reconstruct

Receive News & Ratings for OrthoPediatrics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp. and related companies with MarketBeat.com's FREE daily email newsletter.